Posted on 7월 27, 20227/27/22
EVERSANA’s Continued Commitment to Rare Disease

Posted on 5월 6, 20225/6/22
Case Study: Defining the Rare Disease Patient Journey to Support Commercialization of Therapy

Posted on 4월 14, 20224/14/22
Impact of Patient Reported Outcome Measures on HTA Decisions for Rare Diseases

Posted on 4월 8, 20224/8/22
EVERSANA Featured in NIH Study Detailing the Cost of Treating Rare Disease

Posted on 3월 11, 20223/11/22
Gene Therapy in Today’s Digital World

Posted on 10월 14, 202110/14/21
Webinar: Discover Patient Support Program Needs for Patients with Rare Diseases

Posted on 10월 4, 202110/4/21
WEBINAR: Sustainability in Pharma: Access and Financial Returns

Posted on 10월 1, 202110/1/21